MCHUGH THOMAS S 4
4 · AVADEL PHARMACEUTICALS PLC · Filed Mar 7, 2025
Insider Transaction Report
Form 4
MCHUGH THOMAS S
Chief Financial Officer
Transactions
- Award
Ordinary Shares
2025-03-05+12,600→ 100,400 total - Award
Stock Option (Right to Buy)
2025-03-05+72,000→ 72,000 totalExercise: $7.87Exp: 2030-03-06→ Ordinary Shares (72,000 underlying)
Footnotes (2)
- [F1]Consists of a restricted share award. The restricted share award shall vest in equal annual installments on each of the first four anniversaries following the 3/5/2025 grant date.
- [F2]The options shall vest, if at all, in four equal increments if the volume-weighted average price of the Issuer's Ordinary Shares during any 30 calendar day period exceeds $11, $14, $17 and $19.09, respectively.